Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APCAP: Activated Protein C in Severe Acute Pancreatitis
NCT01017107Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Jun 2003
- Primary completion
- Sep 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute pancreatitis (AP) comparing Activated Protein C with Placebo (2 arms). Primary endpoints: Number of bleedings and Change in Sequential Organ Failure Assessment (SOFA) score at Day 5. Started Jun 2003; status: completed.
02
Drugs
drotrecogin alfa
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT01017107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01017107.